Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

IGC Pharma (IGC) Cash from Operations (2016 - 2025)

Historic Cash from Operations for Pharma (IGC) over the last 17 years, with Q3 2025 value amounting to -$2.1 million.

  • Pharma's Cash from Operations fell 10983.94% to -$2.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$5.5 million, marking a year-over-year decrease of 1405.06%. This contributed to the annual value of -$4.8 million for FY2025, which is 777.07% up from last year.
  • Latest data reveals that Pharma reported Cash from Operations of -$2.1 million as of Q3 2025, which was down 10983.94% from -$1.4 million recorded in Q2 2025.
  • In the past 5 years, Pharma's Cash from Operations registered a high of -$526000.0 during Q1 2024, and its lowest value of -$2.5 million during Q1 2021.
  • For the 5-year period, Pharma's Cash from Operations averaged around -$1.6 million, with its median value being -$1.6 million (2023).
  • Per our database at Business Quant, Pharma's Cash from Operations soared by 6532.63% in 2024 and then plummeted by 10983.94% in 2025.
  • Over the past 5 years, Pharma's Cash from Operations (Quarter) stood at -$2.4 million in 2021, then surged by 31.96% to -$1.6 million in 2022, then rose by 3.7% to -$1.6 million in 2023, then rose by 17.01% to -$1.3 million in 2024, then tumbled by 58.69% to -$2.1 million in 2025.
  • Its last three reported values are -$2.1 million in Q3 2025, -$1.4 million for Q2 2025, and -$730000.0 during Q1 2025.